Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2016 | Research article

Inhibitory effects of an aqueous extract from Cortex Phellodendri on the growth and replication of broad-spectrum of viruses in vitro and in vivo

Authors: Jae-Hoon Kim, Prasanna Weeratunga, Myun Soo Kim, Chamilani Nikapitiya, Byeong-Hoon Lee, Md Bashir Uddin, Tae-Hwan Kim, Ji-Eun Yoon, Chung Park, Jin Yeul Ma, Hongik Kim, Jong-Soo Lee

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

Cortex Phellodendri (C. Phellodendri), the dried trunk bark of Phellodendron amurense Ruprecht, has been known as a traditional herbal medicine, showing several bioactivities. However, antiviral activity of C. Phellodendri aqueous extract (CP) not reported in detail, particularly aiming the prophylactic effectiveness.

Methods

In vitro CP antiviral activity evaluated against Influenza A virus (PR8), Vesicular Stomatitis Virus (VSV), Newcastle Disease Virus (NDV), Herpes Simplex Virus (HSV), Coxsackie Virus (H3-GFP) and Enterovirus-71 (EV-71) infection on immune (RAW264.7) and epithelial (HEK293T/HeLa) cells. Such antiviral effects were explained by the induction of antiviral state which was determined by phosphorylation of signal molecules, secretion of IFNs and cytokines, and cellular antiviral mRNA expression. Furthermore, Compounds present in the aqueous fractions confirmed by HPLC analysis and evaluated their anti-viral activities. Additionally, in vivo protective effect of CP against divergent influenza A subtypes was determined in a BALB/c mouse infection model.

Results

An effective dose of CP significantly reduced the virus replication both in immune and epithelial cells. Mechanically, CP induced mRNA expression of anti-viral genes and cytokine secretion in both RAW264.7 and HEK293T cells. Furthermore, the main compound identified was berberine, and shows promising antiviral properties similar to CP. Finally, BALB/c mice treated with CP displayed higher protection levels against lethal doses of highly pathogenic influenza A subtypes (H1N1, H5N2, H7N3 and H9N2).

Conclusion

CP including berberine play an immunomodulatory role with broad spectrum antiviral activity, due to induction of antiviral state via type I IFN stimulation mechanism. Consequently, C. Phellodendri could be a potential source for promising natural antivirals or to design other antiviral agents for animal and humans.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lemon SM, Mahmoud AA. The threat of pandemic influenza: are we ready? Biosecurity and bioterrorism : biodefense strategy, practice, and science. 2005;3:70–3.CrossRef Lemon SM, Mahmoud AA. The threat of pandemic influenza: are we ready? Biosecurity and bioterrorism : biodefense strategy, practice, and science. 2005;3:70–3.CrossRef
2.
go back to reference Arzt J, White WR, Thomsen BV, Brown CC. Agricultural diseases on the move early in the third millennium. Vet Pathol. 2010;47:15–27.CrossRefPubMed Arzt J, White WR, Thomsen BV, Brown CC. Agricultural diseases on the move early in the third millennium. Vet Pathol. 2010;47:15–27.CrossRefPubMed
3.
go back to reference Mukhtar M, Arshad M, Ahmad M, Pomerantz RJ, Wigdahl B, Parveen Z. Antiviral potentials of medicinal plants. Virus Res. 2008;131:111–20.CrossRefPubMed Mukhtar M, Arshad M, Ahmad M, Pomerantz RJ, Wigdahl B, Parveen Z. Antiviral potentials of medicinal plants. Virus Res. 2008;131:111–20.CrossRefPubMed
4.
go back to reference Xian YF, Mao QQ, Ip SP, Lin ZX. Che CT Comparison on the anti-inflammatory effect of Cortex Phellodendri Chinensis and Cortex Phellodendri Amurensis in 12-O-tetradecanoyl-phorbol-13-acetate-induced ear edema in mice. J Ethnopharm. 2011;137:1425–30.CrossRef Xian YF, Mao QQ, Ip SP, Lin ZX. Che CT Comparison on the anti-inflammatory effect of Cortex Phellodendri Chinensis and Cortex Phellodendri Amurensis in 12-O-tetradecanoyl-phorbol-13-acetate-induced ear edema in mice. J Ethnopharm. 2011;137:1425–30.CrossRef
5.
go back to reference Magadula S. Cytotoxic and anti-HIV activities of some Tanzanian Garcinia species. Tanzania J Health Res. 2010;12(2):1–7.CrossRef Magadula S. Cytotoxic and anti-HIV activities of some Tanzanian Garcinia species. Tanzania J Health Res. 2010;12(2):1–7.CrossRef
6.
go back to reference Strober W. Trypan blue exclusion test of cell viability. Current protocols in immunology. 2001;Appendix 3:Appendix 3B. Strober W. Trypan blue exclusion test of cell viability. Current protocols in immunology. 2001;Appendix 3:Appendix 3B.
7.
go back to reference Moon HJ, Lee JS, Choi YK, Park JY, Talactac MR, Chowdhury MY, Poo H, Sung MH, Lee JH, Jung JU, et al. Induction of type I interferon by high-molecular poly-gamma-glutamate protects B6.A2G-Mx1 mice against influenza A virus. Antiviral Res. 2012;94:98–102.CrossRefPubMed Moon HJ, Lee JS, Choi YK, Park JY, Talactac MR, Chowdhury MY, Poo H, Sung MH, Lee JH, Jung JU, et al. Induction of type I interferon by high-molecular poly-gamma-glutamate protects B6.A2G-Mx1 mice against influenza A virus. Antiviral Res. 2012;94:98–102.CrossRefPubMed
8.
go back to reference Seal BS, King DJ, Bennett JD. Characterization of Newcastle disease virus isolates by reverse transcription PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiological analysis. J clin microb. 1995;33(10):2624–30. Seal BS, King DJ, Bennett JD. Characterization of Newcastle disease virus isolates by reverse transcription PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiological analysis. J clin microb. 1995;33(10):2624–30.
9.
go back to reference Reed JR, Leon RP, Hall MK, Schwertfeger KL. Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. BCR. 2009;11(2):R21.CrossRefPubMedPubMedCentral Reed JR, Leon RP, Hall MK, Schwertfeger KL. Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. BCR. 2009;11(2):R21.CrossRefPubMedPubMedCentral
10.
go back to reference Zhao G, Lin Y, Du L, Guan J, Sun S, Sui H, Kou Z, Chan CC, Guo Y, Jiang S, et al. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol. 2010;7:9.CrossRef Zhao G, Lin Y, Du L, Guan J, Sun S, Sui H, Kou Z, Chan CC, Guo Y, Jiang S, et al. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol. 2010;7:9.CrossRef
11.
go back to reference Yu S, Pang X, Deng Y, Liu L, Liang Y, Liu X, Xie L, Wang G, Wang X. A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis Rhizoma in rat plasma. Int J Mass Spectrom. 2007;268:30–7.CrossRef Yu S, Pang X, Deng Y, Liu L, Liang Y, Liu X, Xie L, Wang G, Wang X. A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis Rhizoma in rat plasma. Int J Mass Spectrom. 2007;268:30–7.CrossRef
12.
go back to reference Shuang-lai Z, Sheng-shan D, Xin-ru L, Run-hui L, Wei-dong Z, Hong-lin H, Yi Z, Yao-hua H, Shu-ping W. Qualitative and Quantitative Analysis of Alkaloids in Cortex Phellodendri by HPLC-ESI-MS_MS and HPLC-DAD. Chem Res Chinese Universities. 2011;27:38–44. Shuang-lai Z, Sheng-shan D, Xin-ru L, Run-hui L, Wei-dong Z, Hong-lin H, Yi Z, Yao-hua H, Shu-ping W. Qualitative and Quantitative Analysis of Alkaloids in Cortex Phellodendri by HPLC-ESI-MS_MS and HPLC-DAD. Chem Res Chinese Universities. 2011;27:38–44.
13.
go back to reference Yan R, Wang Y, Liu Y, Di X. Comparative Pharmacokinetics of Berberine, Palmatine and Jatrorrhizine in Rat Plasma after Oral Administration of Rhizoma coptidis and Zuojinwan Using Liquid Chromatography-Tandem Mass Spectrometry. Iranian J Pharm Res. 2012;11:949–57. Yan R, Wang Y, Liu Y, Di X. Comparative Pharmacokinetics of Berberine, Palmatine and Jatrorrhizine in Rat Plasma after Oral Administration of Rhizoma coptidis and Zuojinwan Using Liquid Chromatography-Tandem Mass Spectrometry. Iranian J Pharm Res. 2012;11:949–57.
14.
go back to reference Huang CY, Tsai YT, Lai JN, Hsu FL. Prescription pattern of chinese herbal products for diabetes mellitus in taiwan: a population-based study. Evid-Based Compl Alt Med. 2013;2013:201329. Huang CY, Tsai YT, Lai JN, Hsu FL. Prescription pattern of chinese herbal products for diabetes mellitus in taiwan: a population-based study. Evid-Based Compl Alt Med. 2013;2013:201329.
15.
go back to reference Takeuchi O, Akira S. Recognition of viruses by innate immunity. Immuno Rev. 2007;220:214–24.CrossRef Takeuchi O, Akira S. Recognition of viruses by innate immunity. Immuno Rev. 2007;220:214–24.CrossRef
16.
17.
go back to reference Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000;13(4):539–48.CrossRefPubMed Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000;13(4):539–48.CrossRefPubMed
18.
go back to reference Zhu X, Wen Z, Xu LZ, Darnell Jr JE. Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol Cell Biol. 1997;17(11):6618–23.CrossRefPubMedPubMedCentral Zhu X, Wen Z, Xu LZ, Darnell Jr JE. Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol Cell Biol. 1997;17(11):6618–23.CrossRefPubMedPubMedCentral
19.
go back to reference Goh KC, Haque SJ, Williams BR. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO. 1999;18(20):5601–8.CrossRef Goh KC, Haque SJ, Williams BR. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO. 1999;18(20):5601–8.CrossRef
20.
go back to reference David M, Petricoin 3rd E, Benjamin C, Pine R, Weber MJ, Larner AC. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science. 1995;269(5231):1721–3.CrossRefPubMed David M, Petricoin 3rd E, Benjamin C, Pine R, Weber MJ, Larner AC. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science. 1995;269(5231):1721–3.CrossRefPubMed
21.
go back to reference Pomerantz JL, Baltimore D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO. 1999;18(23):6694–704.CrossRef Pomerantz JL, Baltimore D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO. 1999;18(23):6694–704.CrossRef
22.
go back to reference Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol cell. 1998;1(5):661–71.CrossRefPubMed Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol cell. 1998;1(5):661–71.CrossRefPubMed
23.
go back to reference Graham KL, Lee LY, Higgins JP, Steinman L, Utz PJ, Ho PP. Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice. Autoimmunity. 2010;43:140–55.CrossRefPubMedPubMedCentral Graham KL, Lee LY, Higgins JP, Steinman L, Utz PJ, Ho PP. Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice. Autoimmunity. 2010;43:140–55.CrossRefPubMedPubMedCentral
24.
go back to reference Kolli D, Velayutham TS, Casola A. Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections. Pathog. 2013;2(2):232–63.CrossRef Kolli D, Velayutham TS, Casola A. Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections. Pathog. 2013;2(2):232–63.CrossRef
25.
go back to reference Magalhaes PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TC, Pessoa Jr A. Methods of endotoxin removal from biological preparations: A review. J Pharm Sci. 2007;10:388–40426. Magalhaes PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TC, Pessoa Jr A. Methods of endotoxin removal from biological preparations: A review. J Pharm Sci. 2007;10:388–40426.
26.
go back to reference Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-cancer drugs. 2009;20:757–69.CrossRefPubMed Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-cancer drugs. 2009;20:757–69.CrossRefPubMed
27.
go back to reference Iwasa K, Kamigauchi M, Ueki M, Taniguchi M. Antibacterial activity and structure-activity relationships of berberine analogs. Euro J Med Chem. 1996;31:469–78.CrossRef Iwasa K, Kamigauchi M, Ueki M, Taniguchi M. Antibacterial activity and structure-activity relationships of berberine analogs. Euro J Med Chem. 1996;31:469–78.CrossRef
28.
go back to reference Iwazaki RS, Endo EH, Ueda-Nakamura T, Nakamura CV, Garcia LB, Filho BP. In vitro antifungal activity of the berberine and its synergism with fluconazole. Anton Leeuw. 2010;97:201–5.CrossRef Iwazaki RS, Endo EH, Ueda-Nakamura T, Nakamura CV, Garcia LB, Filho BP. In vitro antifungal activity of the berberine and its synergism with fluconazole. Anton Leeuw. 2010;97:201–5.CrossRef
29.
go back to reference Hayashi K, Minoda K, Nagaoka Y, Hayashi T, Uesato S. Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorganic & medicinal chemistry letters. 2007;17:1562–4.CrossRef Hayashi K, Minoda K, Nagaoka Y, Hayashi T, Uesato S. Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorganic & medicinal chemistry letters. 2007;17:1562–4.CrossRef
30.
go back to reference Wu Y, Li JQ, Kim YJ, Wu J, Wang Q, Hao Y. In vivo and in vitro antiviral effects of berberine on influenza virus. Chin J Integr Med. 2011;17(6):444–52.CrossRefPubMed Wu Y, Li JQ, Kim YJ, Wu J, Wang Q, Hao Y. In vivo and in vitro antiviral effects of berberine on influenza virus. Chin J Integr Med. 2011;17(6):444–52.CrossRefPubMed
31.
go back to reference Wu JB, Zheng JR, Lin Z, Li XY, Cui PG: Research of antiviral mechanisms of action of berberine derivate HB-13 against herpes simplex virus type 2. Chin. J. Antibiot. 2009; 34:376–79. Wu JB, Zheng JR, Lin Z, Li XY, Cui PG: Research of antiviral mechanisms of action of berberine derivate HB-13 against herpes simplex virus type 2. Chin. J. Antibiot. 2009; 34:376–79.
32.
go back to reference Wu JB, Zheng JR, Lin Z, Li XY, Cui PG: In vitro antiviral activity of a berberine derivant HB-13 against herpes simplex virus. Chin. J. Dermatol. 2007; 40:671-73. Wu JB, Zheng JR, Lin Z, Li XY, Cui PG: In vitro antiviral activity of a berberine derivant HB-13 against herpes simplex virus. Chin. J. Dermatol. 2007; 40:671-73.
Metadata
Title
Inhibitory effects of an aqueous extract from Cortex Phellodendri on the growth and replication of broad-spectrum of viruses in vitro and in vivo
Authors
Jae-Hoon Kim
Prasanna Weeratunga
Myun Soo Kim
Chamilani Nikapitiya
Byeong-Hoon Lee
Md Bashir Uddin
Tae-Hwan Kim
Ji-Eun Yoon
Chung Park
Jin Yeul Ma
Hongik Kim
Jong-Soo Lee
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-016-1206-x

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue